Aprotinin Versus Lysine Analogues: The Debate Continues

This publication has 78 references indexed in Scilit:

• A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass Grafting
  Circulation, 1995
• The Dose-Response Relationship of Tranexamic Acid
  Anesthesiology, 1995
• Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency
  The Journal of Thoracic and Cardiovascular Surgery, 1994
• Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.
  Journal of Clinical Investigation, 1993
• Inhibition of the fibrinolytic and fibrinogenolytic activity of plasminogen activators in vitro by the antidotes ϵ-aminocaproic acid, tranexamic acid and aprotinin
  Fibrinolysis, 1992
• Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery.
  Circulation, 1991
• Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: Potentiation by aspirin and reversal with aprotinin
  Journal of the American College of Cardiology, 1991
• Differential effects of aprotinin and tranexamic acid on cerebral bleeding and cutaneous bleeding time during rt-PA infusion
  Thrombosis Research, 1991
• Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial Revascularization
  Anesthesiology, 1990
• High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage
  Neurosurgery, 1981